GB0122410D0 - Cancer diagnosis - Google Patents

Cancer diagnosis

Info

Publication number
GB0122410D0
GB0122410D0 GB0122410A GB0122410A GB0122410D0 GB 0122410 D0 GB0122410 D0 GB 0122410D0 GB 0122410 A GB0122410 A GB 0122410A GB 0122410 A GB0122410 A GB 0122410A GB 0122410 D0 GB0122410 D0 GB 0122410D0
Authority
GB
United Kingdom
Prior art keywords
cancer diagnosis
diagnosis
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0122410A
Other versions
GB2379738A (en
GB2379738B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACTION AGAINST BREAST CANCER
Original Assignee
ACTION AGAINST BREAST CANCER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACTION AGAINST BREAST CANCER filed Critical ACTION AGAINST BREAST CANCER
Priority to GB0122410A priority Critical patent/GB2379738B/en
Publication of GB0122410D0 publication Critical patent/GB0122410D0/en
Publication of GB2379738A publication Critical patent/GB2379738A/en
Application granted granted Critical
Publication of GB2379738B publication Critical patent/GB2379738B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB0122410A 2001-09-17 2001-09-17 Detecting presence of invasive tumours using oligosaccharide profiling Expired - Fee Related GB2379738B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0122410A GB2379738B (en) 2001-09-17 2001-09-17 Detecting presence of invasive tumours using oligosaccharide profiling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0122410A GB2379738B (en) 2001-09-17 2001-09-17 Detecting presence of invasive tumours using oligosaccharide profiling

Publications (3)

Publication Number Publication Date
GB0122410D0 true GB0122410D0 (en) 2001-11-07
GB2379738A GB2379738A (en) 2003-03-19
GB2379738B GB2379738B (en) 2004-04-14

Family

ID=9922212

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0122410A Expired - Fee Related GB2379738B (en) 2001-09-17 2001-09-17 Detecting presence of invasive tumours using oligosaccharide profiling

Country Status (1)

Country Link
GB (1) GB2379738B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3029622B1 (en) * 2014-12-05 2019-06-14 Safran Aircraft Engines PROCESS FOR FOLLOWING THE MANUFACTURE OF PARTS BASED ON THE ANALYSIS OF CENTERING COEFFICIENTS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1313496C (en) * 1988-04-29 1993-02-09 James Wilson Dennis Diagnostic method to screen tumors
AU775496B2 (en) * 1999-05-17 2004-08-05 Atossa Genetics, Inc. Identifying material from a breast duct

Also Published As

Publication number Publication date
GB2379738A (en) 2003-03-19
GB2379738B (en) 2004-04-14

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
GB2378073B (en) Paper-to-computer interfaces
AU2002360766A8 (en) Methods for cancer imaging
EP1457157A4 (en) Ultrasonograph
EP1383801A4 (en) Antibodies against cancer
GB2396909B (en) Glare-directed imaging
EP1353546A4 (en) Specification
GB0110847D0 (en) Breast cancer detection
EP1411357A4 (en) Cancer diagnostics
GB0216884D0 (en) Diagnostic marker
AU2002360815A8 (en) Human breast cancer biomarkers
GB0115841D0 (en) Ligand
GB0122410D0 (en) Cancer diagnosis
EP1463511A4 (en) Combination cancer therapy
GB0125764D0 (en) Diagnosis of cervicasl cancer
GB0129452D0 (en) Diagnosis of cancer
GB0202562D0 (en) Diagnosis
GB0108587D0 (en) Diagnosis
GB0123630D0 (en) cancer
GB0127668D0 (en) Cancer
GB0115673D0 (en) Cancer
GB0118312D0 (en) Diagnostic
GB0427771D0 (en) Diagnostic marker
GB0310895D0 (en) Cancer diagnosis
PL347055A1 (en) Chronicle-keeping procedures

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20060917

732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
S28 Restoration of ceased patents (sect. 28/pat. act 1977)
S28 Restoration of ceased patents (sect. 28/pat. act 1977)

Effective date: 20080918

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20170917